Skip to main content
Fig. 1 | Diagnostic Pathology

Fig. 1

From: A novel tumor suppressor ASMTL-AS1 regulates the miR-1228-3p/SOX17/β-catenin axis in triple‐negative breast cancer

Fig. 1

ASMTL-AS1 is significantly decreased in TNBC. a The expression of ASMTL-AS1 in GSE45827 database. b qRT-PCR analysis of ASMTL-AS1 expression in 68 matched TNBC and normal tissues. c The overall survival curve of TNBC patients with low and high ASMTL-AS1 levels in our cohort. d-f. The overall, recurrence- or distant metastasis-free survival curve of TNBC patients with low and high ASMTL-AS1 levels in Kaplan-Meier plotter database. ***P < 0.001. The high and low expression level of ASMTL-AS1 in this study was based on median ASMTL-AS1 level in TNBC tissues

Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us